T

Telix Pharmaceuticals

Develops targeted radiation diagnostics and therapies

Director Global Business Resiliency

Business OperationsConfirmed live in the last 24 hours
Full-timeRemote in USANo salary listedRemote

About the Job

Requirements

  • A bachelor's degree or equivalent relevant education and experience is required.
  • At least 10 years of progressive experience in business continuity, crisis management, organizational resiliency, emergency management, or related disciplines, including enterprise or global program leadership.
  • Experience operationalizing and maturing enterprise resiliency programs by translating frameworks and policies into sustainable business practices and measurable capabilities.
  • Experience working in complex, global, highly regulated organizations.
  • Strong knowledge of business continuity, crisis management, emergency preparedness, and organizational resiliency, including ISO 22301, ISO 22320, and BCI Good Practice Guidelines.
  • Ability to influence senior leaders and drive adoption and accountability across a matrix organization.
  • Experience leading executive-level exercises and supporting responses to significant incidents or disruptions.
  • Strong business judgment, executive communication, stakeholder management, and change leadership skills.

Responsibilities

  • Lead the implementation and continued maturation of the global Business Resiliency Management System, translating policies into consistent practices and capabilities across the organization.
  • Drive implementation of resiliency requirements and establish clear business ownership and accountability for delivery.
  • Assess capabilities, identify priority gaps, and establish a practical, risk-based roadmap for continued maturation.
  • Partner with business and functional leaders to integrate resiliency requirements into business operations, planning, and decision-making.
  • Advise senior leadership on material resiliency risks, preparedness, capability gaps, and priorities for improvement and investment.
  • Lead implementation of a consistent, risk-based approach to Business Impact Analysis, continuity planning, recovery strategies, and testing.
  • Ensure critical operations, dependencies, and recovery requirements are identified and reflected in continuity and recovery planning.
  • Partner with IT to align business recovery requirements with technology disaster planning and testing.
  • Work with relevant functions to address resiliency risks associated with critical operational and third-party dependencies.
  • Lead and mature enterprise crisis and incident management capabilities, including escalation, activation, coordination, and recovery preparedness.
  • Strengthen leadership readiness through training, tabletop exercises, simulations, and integrated recovery exercises.
  • Serve as an advisor during significant incidents and crises.
  • Ensure lessons learned from incidents and exercises drive corrective actions and continuous improvement.
  • Establish resiliency metrics, maturity measures, and management reporting.
  • Build organizational awareness and capability through targeted training and engagement.
  • Manage the appropriate mix of internal capability, technology, and specialist external support.

Desired Qualifications

  • Experience in pharmaceutical, biotechnology, radiopharmaceutical, healthcare, manufacturing, life sciences, or a similar regulated industry.
  • Experience partnering with corporate security, EHS, IT, and operational teams to strengthen organizational resilience capabilities.
  • Experience with resiliency technology platforms and externally supported or outsourced program models.
  • Relevant certification such as CBCP, CBCI/MBCI, ISO 22301 Lead Implementer/Auditor, CPP, PSP, or equivalent.

About the Company

Telix Pharmaceuticals

Develops targeted radiation diagnostics and therapies

Telix Pharmaceuticals develops and commercializes diagnostic and therapeutic products that use targeted radiation to diagnose and treat cancer and rare diseases. Its pipeline covers urologic oncology (prostate and kidney cancers), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. The treatments work by delivering targeted radiation to diseased tissues, enabling more precise decisions for treatment and allowing for personalized therapy. The company differentiates itself through a global, robust supply chain and a focus on integrating diagnostic and therapeutic options to address unmet medical needs, along with strong commitments to patient care, ethical practices, and environmental responsibility. Telix’s goal is to improve quality of life and outcomes for patients by providing targeted, clinically meaningful diagnostic and therapeutic solutions that support better treatment decisions and personalized care.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Melbourne VIC, Australia
Founded
2015

Recently Posted Jobs

Explore more opportunities at Telix Pharmaceuticals

See more jobs